Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 5/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | MARS1 | P56192 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.31 |
| ▸ | GCGR | P47871 | 2/20 | 0.31 |
| ▸ | FNTA | P49354 | 3/20 | 0.30 |
| ▸ | FNTB | P49356 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14641786 | 0.90 | MLYCD (0.36) | HDAC4CA1CA2KDM4EALDH1A1 | |
| SCHEMBL29001060 | 0.89 | HDAC4 (0.32) | HDAC4CA1CA2KDM4EALDH1A1 | |
| SCHEMBL29516993 | 0.87 | HDAC4 (0.33) | HDAC4CA1CA2KDM4EALDH1A1 | |
| SCHEMBL2993930 | 0.87 | FNTA (0.33) | CA1CA2KDM4EALDH1A1LMNA | |
| SCHEMBL13769684 | 0.86 | HDAC4 (0.32) | HDAC4CA1CA2KDM4EALDH1A1 | |
| SCHEMBL3105262 | 0.85 | PREP (0.33) | TP53 | |
| SCHEMBL28908172 | 0.84 | CA1 (0.35) | CA1CA2KDM4EALDH1A1 | |
| SCHEMBL30984382 | 0.84 | CA1 (0.32) | CA1CA2 | |
| SCHEMBL28387913 | 0.84 | CA1 (0.34) | CA1CA2 | |
| SCHEMBL12846270 | 0.83 | S1PR1 (0.33) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3351243-A1 | ANIMAL PEST CONTROL METHOD | E. I. du Pont de Nemours and Company (US) | 2018-07-25 | — | — | EP | claimed |
| EP-2957284-B1 | ANIMAL PEST CONTROL METHOD | DU PONT (US) | 2018-01-17 | — | — | EP | claimed |
| EP-2182945-B1 | ANIMAL PEST CONTROL METHOD | DU PONT (US) | 2015-08-05 | — | — | EP | claimed |
| US-11278533-B2 | Animal pest control method | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2022-03-22 | — | — | US | disclosed |
| EP-3927341-A1 | LOW DOSE FLURALANER COMPOSITIONS FOR PROTECTION AGAINST PARASITIC INVERTEBRATE PEST | VIRBAC (FR) | 2021-12-29 | — | — | EP | disclosed |
| WO-2020201440-A1 | LOW DOSE FLURALANER COMPOSITIONS FOR PROTECTION AGAINST PARASITIC INVERTEBRATE PEST | VIRBAC (FR) | 2020-10-08 | — | — | WO | disclosed |
| US-20180353494-A1 | ANIMAL PEST CONTROL METHOD | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2018-12-13 | — | — | US | disclosed |
| EP-3351243-A1 | ANIMAL PEST CONTROL METHOD | E. I. du Pont de Nemours and Company (US) | 2018-07-25 | — | — | EP | disclosed |
| EP-2957284-B1 | ANIMAL PEST CONTROL METHOD | DU PONT (US) | 2018-01-17 | — | — | EP | disclosed |
| US-20160317520-A1 | ANIMAL PEST CONTROL METHOD | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2016-11-03 | — | — | US | disclosed |
| EP-2957284-A1 | ANIMAL PEST CONTROL METHOD | E. I. du Pont de Nemours and Company (US) | 2015-12-23 | — | — | EP | disclosed |
| US-20150272938-A2 | ANIMAL PEST CONTROL METHOD | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-10-01 | — | — | US | disclosed |
| EP-2182945-B1 | ANIMAL PEST CONTROL METHOD | DU PONT (US) | 2015-08-05 | — | — | EP | disclosed |
| US-20100173948-A1 | ANIMAL PEST CONTROL METHOD | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180353494-A1 | ANIMAL PEST CONTROL METHOD | L3MBTL3, C3AR1, C5 | HDAC4 3798/4885CA1 2346/4885CA2 2797/4885 |
| US-11278533-B2 | Animal pest control method | L3MBTL3, C3AR1, C5 | HDAC4 3798/4885CA1 2346/4885CA2 2797/4885 |
| US-20150272938-A2 | ANIMAL PEST CONTROL METHOD | L3MBTL3, C3AR1, C5 | HDAC4 3798/4885CA1 2346/4885CA2 2797/4885 |
| US-20100173948-A1 | ANIMAL PEST CONTROL METHOD | L3MBTL3, C3AR1, C5 | HDAC4 3798/4885CA1 2346/4885CA2 2797/4885 |
| US-20160317520-A1 | ANIMAL PEST CONTROL METHOD | L3MBTL3, C3AR1, C5 | HDAC4 3798/4885CA1 2346/4885CA2 2797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.